Alyeska Investment Group, L.P.

Q3 2013 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Jason Bragg - Chief Financial Officer
Location
Chicago, IL
Holdings as of
30 Sep 2013
Value $
$53,409,000
Num holdings
7
Filing time
20 Feb 2014, 12:14:10 UTC
Form type
13F-HR/A-1 - New Holdings
Description
Top holdings included ELN, NYX, MOLXA, LIFE, and ACTV. Request for Confidential Treatment (14 Nov 2013): Confidential Treatment Expired on 14 Feb 2014.
Next filing
Q4 2013 - 14 Feb 2014
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 14 Nov 2013 pursuant to a request for confidential treatment and for which confidential treatment expired on 14 Feb 2014.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Jason Bragg Chief Financial Officer Chicago, Illinois 20 Feb 2014

Other Included Managers (1):

Num Name Location File Number
1 Alyeska Master Fund, L.P. Chicago, IL 028-13417